Axsome Therapeutics Appoints Myrtle Potter to its Board of Directors
19 juin 2017 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, June 19, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...